Home / News & Insights

News & Insights

Type
Sector
Sub Sector
Reports
16th February 2023

Pharma Commercialisation Services Update – February 2023

Welcome to our latest update on the outsourced Pharma Commercialisation Services sector. In this report we will be reviewing deal activity across 2022 and taking a look forward to see what 2023 may hold for the sector. We hope that you enjoy this report and look forward to discussing the data and underlying themes with […]

Read More
Reports
16th August 2022

Marketing Services: Global M&A and Public Company Performance – H1 2022

We are pleased to share with you the H1 2022 Marketing Services Sector Review, where we analyse global M&A activity and public market performance in the marketing services sector. H1 2022 has been an exciting and active period for M&A in the marketing services vertical with 425 deals recorded globally. This represents a 15% and […]

Read More
Events
26th May 2023

BIO International Convention June 13-16, 2022 – San Diego, CA

Date:
13/06/2022
Venue:
San Diego, CA, USA
Read More
Events
19th May 2023

BIO 2023, 5 – 8 June

Date:
05/06/2023
Venue:
Boston Convention & Exhibition Center - Boston, MA
Read More
Events
20th February 2023

BIO-Europe Spring March 20 – 22, 2023

Date:
20/03/2023
Venue:
Messe Basel, Switzerland
Read More
Events
13th February 2023

DCAT Week, 20 – 23 March 2023

Date:
20/03/2023
Venue:
New York City
Read More
Events
5th December 2022

JP Morgan 2023

Date:
09/01/2023
Venue:
Westin St. Francis in San Francisco, CA
Read More
Insights
5th December 2022

The end of the ecommerce boom or the start of a new era of innovation and digital disruption?

Katherine Hobbs, Director at CG Results and Neil Trickett Managing Director of E2X discuss the outlook for ecommerce and why, despite the headlines, they see opportunities for operators and investors across the sector over the next 18-24 months As Black Friday and Cyber Monday draw to a close, you could be forgiven for concluding that […]

Read More
Reports
23rd November 2022

Pharma Licensing – an introduction

We are pleased to share our introduction to Pharma Licensing. This guide provides an overview of both in and out-licensing as well as insights on what to anticipate during the process. We hope that you find this guide useful and look forward to discussing the underlying themes with you. Do get in touch! Click to […]

Read More
Events
9th November 2022

Women in Corporate Finance

Date:
02/02/2023
Venue:
33 Foley Street, London, W1W 7TL
Read More
Insights
17th October 2022

Pharma Licensing: the why the how and a few things to get right

Platform or asset licensing has increasingly been utilised across the bio-pharmaceutical industry to achieve Corporate objectives by sharing intellectual property (IP).  IP includes patents and know-how and third-party proprietary technologies, compounds and products, and can be used to build on existing therapeutic areas, expand into different geographies or to diversify portfolios.  A pharma licensing deal […]

Read More

Subscribe

We add value by understanding our sectors inside-out, and we release regular industry research and reports on key trends in the technology and healthcare sectors. Fill out the form to start receiving alerts when we publish new content or to follow our latest deals, upcoming events and company updates.

  • *
  • This field is for validation purposes and should be left unchanged.